
Top stories






HR & ManagementSubstance abuse is costing companies dearly: Here’s what they can do about it
Harmony Clinic 26 May 2025
More news



Marketing & Media
Capitec’s new jingle makes banking fees as easy as 1, 2, 3, 6, 10















The authors from the Complutense University in Madrid, working with scientists from other universities, found that the active component of marijuana, tetrahydrocannabinol (THC), causes cancer cells to undergo a process called autophagy, the breakdown that occurs when the cell essentially self-digests.
The research, which appears in the April edition of US-published Journal of Clinical Investigation, demonstrates that THC and related "cannabinoids" appear to be "a new family of potential antitumoral agent."
The authors wrote that the chemical may prove useful in the development of future "antitumoral agents."
The scientists conducted their research on mice, first stimulating the growth of cancer in the lab animals, then injecting them with a daily dose of THC near the site of their tumors.
The researchers also analysed the tumors of two patients in an experimental trial looking at the effects of THC on a highly aggressive form of brain tumor, and saw findings "in line with the preclinical evidence" first observed in the laboratory mice.
Source: AFP
Published courtesy of